XML 79 R69.htm IDEA: XBRL DOCUMENT
v3.23.3

COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands | Oct. 23, 2023 USD ($) installment | Aug. 03, 2023 USD ($) | Dec. 21, 2020 patent | Sep. 30, 2023 USD ($) | Sep. 07, 2023 USD ($) | Dec. 31, 2022 USD ($)
--- | --- | --- | --- | --- | --- | ---
Loss Contingencies [Line Items] |  |  |  |  |  |
Legal charges pending settlement |  |  |  | $ 62,800 |  | $ 0
Myriad Genetics, Inc. Securities Litigation |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement |  | $ 77,500 |  |  |  |
Litigation settlement, amount awarded to other party, cash |  | 20,000 |  |  | $ 20,000 |
Litigation settlement, amount awarded to other party, common stock |  | 57,500 |  |  |  |
Litigation settlement, amount awarded to other party, elected payment |  | $ 57,500 |  |  |  |
Litigation settlement, period to determine awarded common stock |  | 10 days |  |  |  |
Litigation settlement, number of outstanding shares, common stock |  | 5.00% |  |  |  |
Myriad Genetics, Inc. Securities Litigation | Pending Litigation |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Legal charges pending settlement |  |  |  | 57,500 |  |
Raygen, Inc vs. Myriad Women's Health, Inc. |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Number of patents allegedly infringed | patent |  |  | 2 |  |  |
Accrual |  |  |  | 34,000 |  |
Accrual, noncurrent |  |  |  | 29,000 |  |
Accrual, current |  |  |  | $ 5,000 |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | $ 21,250 |  |  |  |  |
Number of annual installments | installment | 5 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | First Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | $ 5,000 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Second Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | 5,000 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Third Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | 5,000 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Fourth Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | 5,000 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Contingent Payments | Subsequent Event | Final Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | 1,250 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | $ 12,750 |  |  |  |  |
Number of annual installments | installment | 3 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event | First Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | $ 5,000 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event | Second Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | 5,000 |  |  |  |  |
Raygen, Inc vs. Myriad Women's Health, Inc. | Settled Litigation, Non-Contingent Payments | Subsequent Event | Third Installment |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreement | $ 2,750 |  |  |  |  |

X
- Definition Litigation Settlement, Amount Awarded To Other Party, Cash + References No definition available. + Details
Name: | mygn_LitigationSettlementAmountAwardedToOtherPartyCash
Namespace Prefix: | mygn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Litigation Settlement, Amount Awarded To Other Party, Common Stock + References No definition available. + Details
Name: | mygn_LitigationSettlementAmountAwardedToOtherPartyCommonStock
Namespace Prefix: | mygn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Litigation Settlement, Amount Awarded To Other Party, Elected Payment + References No definition available. + Details
Name: | mygn_LitigationSettlementAmountAwardedToOtherPartyElectedPayment
Namespace Prefix: | mygn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Litigation Settlement, Number Of Installments + References No definition available. + Details
Name: | mygn_LitigationSettlementNumberOfInstallments
Namespace Prefix: | mygn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Litigation Settlement, Percentage Of Outstanding Shares, Common Stock + References No definition available. + Details
Name: | mygn_LitigationSettlementPercentageOfOutstandingSharesCommonStock
Namespace Prefix: | mygn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Litigation Settlement, Period To Determine Awarded Common Stock + References No definition available. + Details
Name: | mygn_LitigationSettlementPeriodToDetermineAwardedCommonStock
Namespace Prefix: | mygn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_LitigationReserveCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount awarded to other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss contingency liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10 + Details
Name: | us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingencyAccrualCarryingValueCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 + Details
Name: | us-gaap_LossContingencyAccrualCarryingValueNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of another entity's patents that the entity has allegedly infringed. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=mygn_MyriadGeneticsIncSecuritiesLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=mygn_RaygenIncVersusMyriadWomensHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=mygn_SettledLitigationContingentPaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_FirstInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_SecondInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_ThirdInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_FourthInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | mygn_LitigationInstallmentsAxis=mygn_FifthInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=mygn_SettledLitigationNonContingentPaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |